A copeptin-based classification of the osmoregulatory defects in the syndrome of inappropriate antidiuresis

Journal of the American Society of Nephrology

Volumn 25, Issue 10, 2014, Pages 2376-2383

  Fenske, Wiebke Kristin ^a,b   Christ Crain, Mirjam ^c   Hörning, Anna ^a   Simet, Jessica ^a   Szinnai, Gabor ^d   Fassnacht, Martin ^a,e   Rutishauser, Jonas ^f   Bichet, Daniel G ^g   Störk, Stefan ^a   Allolio, Bruno ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^e UNIVERSITY OF MUNICH   (Germany)

^f Cantonal Hospital Baselland   (Switzerland)

^g UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; COPEPTIN; SODIUM; SODIUM CHLORIDE; GLYCOPEPTIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HUMAN; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; MALE; OSMOREGULATION; OSMOSIS; PRIORITY JOURNAL; SERUM OSMOLALITY; SODIUM BLOOD LEVEL; AGED; BLOOD; CASE CONTROL STUDY; CLASSIFICATION; DNA SEQUENCE; MIDDLE AGED; NORMAL HUMAN; YOUNG ADULT;

ADULT; AGED; ARGININE VASOPRESSIN; CASE-CONTROL STUDIES; FEMALE; GLYCOPEPTIDES; HEALTHY VOLUNTEERS; HUMANS; INAPPROPRIATE ADH SYNDROME; MALE; MIDDLE AGED; OSMOREGULATION; SALINE SOLUTION, HYPERTONIC; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84901915839     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013080895     Document Type: Article

References (31)

1. Upadhyay A, Jaber BL, Madias NE: Incidence and prevalence of hyponatremia. Am J Med 119[Suppl 1]: S30-S35, 2006
2. Waikar SS, Mount DB, Curhan GC: Mortality after hospitalization with mild, moderate, and severe hyponatremia. Am J Med 122: 857-865, 2009
3. Klein L, O'Connor CM, Leimberger JD, Gattis-Stough W, Piña IL, Felker GM, Adams KF Jr, Califf RM, Gheorghiade M; OPTIME-CHF Investigators: Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study. Circulation 111: 2454-2460, 2005
4. Schwartz WB, Bennett W, Curelop S, Bartter FC: A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am J Med 23: 529-542, 1957
5. Zerbe R, Stropes L, Robertson G: Vasopressin function in the syndrome of inappropriate antidiuresis. Annu Rev Med 31: 315-327, 1980
6. Soupart A, Gross P, Legros JJ, Alföldi S, Annane D, Heshmati HM, Decaux G: Successful long-term treatment of hyponatremia in syndrome of inappropriate antidiuretic hormone secretion with satavaptan (SR121463B), an orally active nonpeptide vasopressin V2-receptor antagonist. Clin J Am Soc Nephrol 1: 1154-1160, 2006
7. Robertson GL: Vaptans for the treatment of hyponatremia. Nat Rev Endocrinol 7: 151-161, 2011
8. Fenske W, Quinkler M, Lorenz D, Zopf K, Haagen U, Papassotiriou J, Pfeiffer AF, Fassnacht M, Störk S, Allolio B: Copeptin in the differential diagnosis of the polydipsia-polyuria syndrome-revisiting the direct and indirect water deprivation tests. J Clin Endocrinol Metab 96: 1506-1515, 2011
9. Decaux G, Vandergheynst F, Bouko Y, Parma J, Vassart G, Vilain C: Nephrogenic syndrome of inappropriate antidiuresis in adults: High phenotypic variability in men and women from a large pedigree. J Am Soc Nephrol 18: 606-612, 2007
10. Smith D, Moore K, Tormey W, Baylis PH, Thompson CJ: Downward resetting of the osmotic threshold for thirst in patients with SIADH. AmJ Physiol Endocrinol Metab 287: E1019-E1023, 2004
11. Robertson GL, Mahr EA, Athar S, Sinha T: Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma. J Clin Invest 52: 2340-2352, 1973
12. Kamoi K, Tamura T, Tanaka K, Ishibashi M, Yamaji T: Hyponatremia and osmoregulation of thirst and vasopressin secretion in patients with adrenal insufficiency. J Clin Endocrinol Metab 77: 1584-1588, 1993
13. McGee S, Abernethy WB 3rd, Simel DL: The rational clinical examination. Is this patient hypovolemic? JAMA 281: 1022-1029, 1999
14. Fenske W, Störk S, Koschker AC, Blechschmidt A, Lorenz D, Wortmann S, Allolio B: Value of fractional uric acid excretion in differential diagnosis of hyponatremic patients on diuretics. J Clin Endocrinol Metab 93: 2991-2997, 2008
15. Verbalis JG: Disorders of body water homeostasis. Best Pract Res Clin Endocrinol Metab 17: 471-503, 2003
16. Robertson GL, Athar S: The interaction of blood osmolality and blood volume in regulating plasma vasopressin in man. J Clin Endocrinol Metab 42: 613-620, 1976
17. Dunn FL, Brennan TJ, Nelson AE, Robertson GL: The role of blood osmolality and volume in regulating vasopressin secretion in the rat. J Clin Invest 52: 3212-3219, 1973
18. Andresen MC, Doyle MW, Jin YH, Bailey TW: Cellular mechanisms of baroreceptor integration at the nucleus tractus solitarius. Ann NY Acad Sci 940: 132-141, 2001
19. Renaud LP: CNS pathways mediating cardiovascular regulation of vasopressin. Clin Exp Pharmacol Physiol 23: 157-160, 1996
20. Blessing WW, Sved AF, Reis DJ: Destruction of noradrenergic neurons in rabbit brainstemelevates plasma vasopressin, causing hypertension. Science 217: 661-663, 1982
21. Amatruda TT Jr, Mulrow PJ, Gallagher JC, Sawyer WH: Carcinoma of the Lung with Inappropriate Antidiuresis. Demonstration of Anti-diuretic- Hormone-Like Activity in Tumor Extract. N Engl J Med 269: 544-549, 1963
22. George JM, Capen CC, Phillips AS: Biosynthesis of vasopressin in vitro and ultrastructure of a bronchogenic carcinoma. Patient with the syndrome of inappropriate secretion of antidiuretic hormone. J Clin Invest 51: 141-148, 1972
23. Robertson GL, Aycinena P, Zerbe RL: Neurogenic disorders of osmoregulation. Am J Med 72: 339-353, 1982
24. De Koninck Y: Altered chloride homeostasis in neurological disorders: A new target. Curr Opin Pharmacol 7: 93-99, 2007
25. Babey M, Kopp P, Robertson GL: Familial forms of diabetes insipidus: clinical and molecular characteristics. Nat Rev Endocrinol 7: 701-714, 2011
26. Berliner RW, Davidson DG: Production of hypertonic urine in the absence of pituitary antidiuretic hormone. J Clin Invest 36: 1416-1427, 1957
27. Block LH, Furrer J, Locher RA, Siegenthaler W, Vetter W: Changes in tissue sensitivity to vasopressin in hereditary hypothalamic diabetes insipidus. Klin Wochenschr 59: 831-836, 1981
28. Szinnai G, Morgenthaler NG, Berneis K, Struck J, Müller B, Keller U, Christ-Crain M: Changes in plasma copeptin, the c-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects. J Clin Endocrinol Metab 92: 3973-3978, 2007
29. Fenske W, Störk S, Blechschmidt A, Maier SG, Morgenthaler NG, Allolio B: Copeptin in the differential diagnosis of hyponatremia. J Clin Endocrinol Metab 94: 123-129, 2009
30. Kamoi K, Toyama M, Takagi M, Koizumi T, Niishiyama K, Takahashi K, Sasaki H, Muto T: Osmoregulation of vasopressin secretion in patients with the syndrome of inappropriate antidiuresis associated with central nervous system disorders. Endocr J 46: 269-277, 1999
31. Robertson G: Posterior Pituitary. In: Endocrinology and Metabolism, 3rd Ed., edited by Baxter JD, Felig F, Frohman LA, New York, McGraw-Hill, 1995, pp 385-432.